CapitaLand Investment's (SGX:9CI) workforce in China dropped by around 10% in 2025, with the real estate firm impacted by an industry crisis in the region, according to the company's sustainability report published late Saturday.
The company's headcount shrunk to 9,542 employees in 2025, compared with 10,158 in the prior period.
Hanmi Pharm (KRX:128940) signed a technology licensing agreement for Sonefpeglutide (HM15912), a short bowel syndrome drug, with Eli Lilly and Co., according to a Monday filing with the Korea Exchange.The technology licensing agreement is worth up to $1.26 billion, including a $75 million upfront payment and up to $1.185 billion in development, regulatory, and commercial milestones, along with royalties based on future sales, the filing said.Shares of Hanmi Pharm rose more than 7% in recent trade.
Shares of SoftBank Group (TYO:9984) rose sharply in Monday's early trading session, pushing its market capitalization to over 47 trillion yen, making it the most valuable company on the Tokyo exchange for the first time in over two decades.The tech conglomerate's stock jumped over 10% to 8,259 yen at 11:30 am in Tokyo on Monday.SoftBank has overtaken the long-time leader, Toyota Motor (TYO:7203), and now holds a market value of 45.7 trillion yen.Toyota's shares fell 4.8% in recent trade.
Information technology stocks advanced more than 5% at midday Monday.Xero (ASX:XRO) gained 8% in recent trade.On the flip side, the healthcare sector struggled, shedding nearly 2%.CSL (ASX:CSL) shares fell almost 2% in recent trade.